Showing results (251-260 of 583) with videos related to

Sort By:
Pageof 59
Journal of Gastric Cancer|July 14, 2012
The impact of obesity on the use of a totally laparoscopic distal gastrectomy in patients with gastric cancerEiji Oki, Yoshihisa Sakaguchi, Kippei Ohgaki, et al.
Transplantation|June 4, 2014
Use of living donor liver grafts with double or triple arteriesHideaki Uchiyama, Ken Shirabe, Tomoharu Yoshizumi, et al.
Annals of Surgical Oncology|June 26, 2014
Clinicopathological characteristics of esophageal squamous cell carcinoma in patients younger than 50 yearsYuta Kasagi, Masaru Morita, Hajime Otsu, et al.
International Journal of Clinical Oncology|November 26, 2024
The clinical significance of signal regulatory protein alpha expression in the immune environment of gastric cancerYasushi Tanaka, Qingjiang Hu, Tetsuro Kawazoe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancerYoshihiro Tanaka, Shingo Miyamoto, Satoshi O Suzuki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 6, 2013
Mortalin is a prognostic factor of gastric cancer with normal p53 functionKoji Ando, Eiji Oki, Yan Zhao, et al.
Cancer Medicine|October 25, 2013
Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cellsAyae Ikawa-Yoshida, Koji Ando, Eiji Oki, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatinGreg Yothers, Alan P Venook, Eiji Oki, et al.
Molecular Oncology|April 16, 2026
Proteasome inhibitor, ixazomib prevents topoisomerase-I degradation and reverses irinotecan resistance in colorectal cancerYuho Ebata, Koji Ando, Hirofumi Hasuda, et al.
Surgery Today|January 27, 2012
Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgeryToshiro Okuyama, Daisuke Korenaga, Ai Edagawa, et al.
Pageof 59